Low-level Laser Therapy as an Adjunct to Non-surgical Periodontal Treatment
Study Details
Study Description
Brief Summary
The present study aimed to investigate the effects of low-level laser therapy (LLLT) as an adjunct to non-surgical periodontal treatment (NSPT) on the plasminogen-activating system in Stage 3-4, Grade C periodontitis patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Limited data is available regarding the effects of various periodontal treatment protocols on GCF t-PA and PAI-1 levels, and the extent to which LLLT in conjunction with NSPT affects these levels in patients with Stage 3-4, Grade C periodontitis is unknown. Therefore, this study measured standard clinical outcomes and GCF t-PA and PAI-1 levels in patients with Stage 3-4 Grade, C periodontitis in order to assess the use of LLLT as an adjunct to standard NSPT.
This split-mouth study was conducted with 15 Stage 3-4, Grade C periodontitis patients and 15 healthy individuals matched for age and sex. Participants were grouped as follows: Periodontitis/NSPT (Sham); Periodontitis/NSPT+LLLT (LLLT); Periodontally Healthy (Control). LLLT was applied following NSPT and again on post-treatment Days 2 and 7. Clinical parameters were recorded at baseline (i.e. before NSPT) and on Day 30. Gingival crevicular fluid (GCF) samples were collected at baseline and during follow-up visits on Days 7, 14 and 30. GCF t-PA and PAI-1 levels were measured with ELISA.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Sham Comparator: non-surgical perıodontal treatment
|
Procedure: non-surgical periodontal treatment
standart periodontal therapy
|
Experimental: non-surgical treatment+ low level laser therapy
|
Procedure: low level laser therapy
adjunctive application of low level laser therapy to non-surgical periodontal treatment
Procedure: non-surgical periodontal treatment
standart periodontal therapy
|
Outcome Measures
Primary Outcome Measures
- the change in GCF tissue plasminogen activator [baseline and during follow-up visits on Days 7, 14 and 30.]
Gingival crevicular fluid (GCF) samples were collected before SRP treatment and on days 7, 14 and 30 of follow- up and the change of the related mediator at those time points. The Amount of the related mediator were evaluated using enzyme- linked immunosorbent assay [ELISA] kit. Total amounts (pg/30 s) of the mediator collected from each sample in a 30- second period were calculated and recorded for analysis.
- the change in GCF plasminogen activator inhibitor 1 [baseline and during follow-up visits on Days 7, 14 and 30.]
Gingival crevicular fluid (GCF) samples were collected before SRP treatment and on days 7, 14 and 30 of follow- up and the change of the related mediator at those time points. The Amount of the related mediator were evaluated using enzyme- linked immunosorbent assay [ELISA] kit. Total amounts (pg/30 s) of the mediator collected from each sample in a 30- second period were calculated and recorded for analysis.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Stage 3-4, Grade C periodontitis (at least one site with probing depth (PD) and clinical attachment level (CAL) ≥5 mm in their incisors and/or first molars and at least 6 other teeth with similar PD and CAL measurements, with alveolar bone loss confirmed by radiography; familial aggregation;
-
presence of ≥16 teeth;
-
no periodontal treatment in the 6 months prior to data collection;
-
non-smoker
Exclusion Criteria:
-
systemic problems, including a medical history of cancer, rheumatoid arthritis, diabetes mellitus, or cardiovascular disease;
-
compromised immune system;
-
pregnancy, menopause, or lactation;
-
ongoing drug therapy that might affect the clinical characteristics of periodontitis;
-
use of systemic antimicrobials during the 6 weeks prior to data collection
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Beykent University | Istanbul | Turkey |
Sponsors and Collaborators
- University of Beykent
Investigators
- Principal Investigator: Ferda Pamuk Özer, Beykent University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- interventional